Intrinsic Value of S&P & Nasdaq Contact Us

Sonova Holding AG SONVY OTC

Other OTC • Healthcare • Medical - Devices • CH • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Sonova Holding AG (SONVY) trades at a trailing P/E of 26.5, forward P/E of 25.1. Trailing earnings yield is 3.78%, forward earnings yield 3.99%. PEG 4.56.

Criteria proven by this page:

  • VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Forward P/E 25.1 (down from trailing 26.5) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 4.56 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 3.78% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 3.99% as earnings recover.

Overall SharesGrow Score: 58/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
76/100
→ Income
GROWTH
30/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — SONVY

Valuation Multiples
P/E (TTM)26.5
Forward P/E25.1
PEG Ratio4.56
Forward PEG4.56
P/B Ratio0.00
P/S Ratio3.70
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.81
Forward EPS (Est.)$1.91
Book Value / Share$0.00
Revenue / Share$12.93
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.78%
Forward Earnings Yield3.99%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.01 $2.07B $337.03M 16.3%
2017 $1.06 $2.4B $349.17M 14.6%
2018 $1.21 $2.65B $400.1M 15.1%
2019 $1.38 $2.76B $454.1M 16.4%
2020 $1.50 $2.92B $483.2M 16.6%
2021 $1.84 $2.6B $581M 22.3%
2022 $2.07 $3.36B $649M 19.3%
2023 $2.14 $3.74B $647.5M 17.3%
2024 $2.01 $3.63B $601M 16.6%
2025 $1.81 $3.87B $540.5M 14%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message